AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BCAL DIAGNOSTICS LTD

0.058

+0.0023.57%

Volume:11.07K

Turnover:642

Market Cap:21.35M

PE:-2.91

High:0.058

Open:0.058

Low:0.058

Close:0.056

52wk High:0.155

52wk Low:0.052

Shares:368.07M

Float Shares:202.44M

Volume Ratio:0.09

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.020

EPS(LYR):-0.020

ROE:-121.67%

ROA:-46.59%

PB:8.55

PE(LYR):-2.88

Loading ...

Overview Company News Filings

RBC Cuts Price Target on Becton, Dickinson to $175 From $195, Keeps Sector Perform Rating

MT Newswires Live

Becton, Dickinson Seeks EU Approval for New Liver Disease Stent Device

MT Newswires Live

BRIEF-BCAL Diagnostics Submits MSAC Application For Avantect Pancreatic Cancer Early Detection Blood Test

BCAL Diagnostics Ltd - Submits Msac Application for Avantect Pancreatic Cancer Early Detection Blood Test

THOMSON REUTERS

Argus Research Adjusts Becton, Dickinson and Company Price Target to $180 From $230, Maintains Buy Rating

MT Newswires Live

Is There Now An Opportunity In Becton Dickinson (BDX) After Recent Share Price Weakness

Simply Wall St.

Becton Dickinson Launches Three-Tube Urine Collection System

MT Newswires Live

Evaluating Becton Dickinson (BDX) After Earnings Strength Guidance Reaffirmation And Debt Tender Activity

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BDX.AU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BDX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BDX.AU\",,,,,undefined,":{"symbol":"BDX.AU","market":"AU","secType":"STK","nameCN":"BCAL DIAGNOSTICS LTD","latestPrice":0.058,"timestamp":1787292720000,"preClose":0.056,"halted":0,"volume":11072,"delay":0,"changeRate":0.03571428571428575,"nameEN":"BCAL DIAGNOSTICS LTD","floatShares":202437334,"shares":368067640,"eps":-0.01993,"marketStatus":"Not Yet Opened","change":0.002,"latestTime":"08-21 16:12:00 AEST","open":0.058,"high":0.058,"low":0.058,"amount":642,"amplitude":0,"askPrice":0.074,"askSize":43400,"bidPrice":0.054,"bidSize":6350,"shortable":3,"etf":0,"ttmEps":-0.01993,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.056,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":0.0858957768144436,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"BDX.AU","preClose":0.065,"auctionPrice":0.063,"auctionVolume":3076,"auction":3,"marketStatus":"盘后竞价","timestamp":1786341616106}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BDX.AU\",,,,,undefined,":{"symbol":"BDX.AU","floatShares":202437334,"roa":"-46.59%","roe":"-121.67%","lyrEps":-0.020136,"volumeRatio":0.0858957768144436,"shares":368067640,"dividePrice":0,"high":0.058,"amplitude":0,"preClose":0.056,"low":0.058,"week52Low":0.052,"pbRate":"8.55","psRate":"8.41","week52High":0.155,"institutionHeld":0,"latestPrice":0.058,"committee":-0.744724,"eps":-0.01993,"divideRate":0,"volume":11072,"delay":0,"ttmEps":-0.01993,"open":0.058,"prevYearClose":0.105,"prevWeekClose":0.056,"prevMonthClose":0.067,"prevQuarterClose":0.075,"fiveDayClose":0.056,"twentyDayClose":0.078,"sixtyDayClose":0.076},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BDX.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BDX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BDX.AU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2627144872","title":"RBC Cuts Price Target on Becton, Dickinson to $175 From $195, Keeps Sector Perform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2627144872","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627144872?lang=en_us&edition=fundamental","pubTime":"2026-04-14 19:27","pubTimestamp":1776166042,"startTime":"0","endTime":"0","summary":"Becton, Dickinson (BDX) has an average rating of overweight and mean price target of $187.18, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","LU0072461881.USD","LU0266013472.USD","LU0006061336.USD","LU0162691827.USD","LU1894683264.USD","LU1854104046.USD","IE00BFXG1179.USD","LU0648000940.SGD","LU0511384066.AUD","LU1854103824.USD","BDX","LU0130518102.USD","BK4585","LU0477156797.USD","LU1150488135.SGD","BK4082","LU0433182093.SGD","LU1059921491.USD","LU0130103400.USD","LU0289961442.SGD","BK4588","LU1571399168.USD","LU0878866978.SGD","LU1489326972.SGD","LU1894683348.USD","BDX.AU","LU0289739343.SGD","BK4504","LU0068578508.USD","LU0985320562.USD","LU1150488218.USD","LU1201861165.SGD","LU0985489474.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625943620","title":"Becton, Dickinson Seeks EU Approval for New Liver Disease Stent Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2625943620","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625943620?lang=en_us&edition=fundamental","pubTime":"2026-04-08 19:09","pubTimestamp":1775646578,"startTime":"0","endTime":"0","summary":"Becton, Dickinson  said it has applied for a CE Mark in the European Union for its Liverty TIPS Stent Graft, a next-generation device designed to treat complications from portal hypertension in the liver.The company said the device targets patients with cirrhosis, a condition affecting an estimated 58 million people globally, and aims to improve outcomes by reducing elevated blood pressure in the liver through TIPS procedures.The Liverty stent features an adjustable diameter, flexible self-expanding frame, and advanced coating designed for precision placement and durability, the company added.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0477156797.USD","LU1854104046.USD","LU0289739343.SGD","LU1150488218.USD","LU0433182093.SGD","BK4585","LU1894683348.USD","LU0878866978.SGD","BK4082","LU0985489474.SGD","LU1150488135.SGD","LU0985320562.USD","IE00BFXG1179.USD","LU0511384066.AUD","LU0648000940.SGD","BDX.AU","LU0006061336.USD","LU0266013472.USD","LU0162691827.USD","LU1059921491.USD","BK4156","BK7067","LU0068578508.USD","LU0130518102.USD","BDX","LU1571399168.USD","LU1489326972.SGD","BK4588","LU0130103400.USD","LU1201861165.SGD","LU0289961442.SGD","LU1894683264.USD","LU0072461881.USD","BK4504","LU1854103824.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623940376","title":"BRIEF-BCAL Diagnostics Submits MSAC Application For Avantect Pancreatic Cancer Early Detection Blood Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2623940376","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623940376?lang=en_us&edition=fundamental","pubTime":"2026-03-31 09:52","pubTimestamp":1774921940,"startTime":"0","endTime":"0","summary":"BRIEF-BCAL Diagnostics Submits MSAC Application For Avantect Pancreatic Cancer Early Detection Blood TestMarch 31  - BCAL Diagnostics Ltd BDX.AX:SUBMITS MSAC APPLICATION FOR AVANTECT PANCREATIC CANCER EARLY DETECTION BLOOD TESTFurther company coverage: BDX.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nFWN40I1CL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623322392","title":"BCAL Diagnostics Ltd - Submits Msac Application for Avantect Pancreatic Cancer Early Detection Blood Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2623322392","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623322392?lang=en_us&edition=fundamental","pubTime":"2026-03-31 06:11","pubTimestamp":1774908691,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nFWN40I1CL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BDX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621703743","title":"Argus Research Adjusts Becton, Dickinson and Company Price Target to $180 From $230, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2621703743","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621703743?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:22","pubTimestamp":1774268568,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Company (BDX) has an average rating of overweight and mean price target of $191.20, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0068578508.USD","LU0130103400.USD","LU1150488135.SGD","BK4585","LU1201861165.SGD","LU0985320562.USD","LU1854104046.USD","LU0878866978.SGD","LU0130518102.USD","LU1894683348.USD","LU0433182093.SGD","LU1059921491.USD","BK7067","LU0266013472.USD","LU0477156797.USD","LU0072461881.USD","BK4504","LU0006061336.USD","LU1894683264.USD","BDX","BDX.AU","LU0511384066.AUD","LU1854103824.USD","BK4082","LU0162691827.USD","LU0985489474.SGD","LU0289739343.SGD","LU1571399168.USD","LU0289961442.SGD","BK4588","IE00BFXG1179.USD","LU1150488218.USD","LU1489326972.SGD","LU0648000940.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619124959","title":"Is There Now An Opportunity In Becton Dickinson (BDX) After Recent Share Price Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=2619124959","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619124959?lang=en_us&edition=fundamental","pubTime":"2026-03-14 22:24","pubTimestamp":1773498291,"startTime":"0","endTime":"0","summary":"If you are wondering whether Becton Dickinson's current share price reflects its true worth, you are not alone. This article will walk you through what the numbers are saying about value.\nBecton Dickinson's share price closed at US$159.36, with returns of a 4.6% decline over 7 days, an 11.8% decline over 30 days, an 18.3% decline year to date, an 8.2% decline over 1 year, a 9.0% decline over 3 years and a 5.4% decline over 5 years. This raises questions about how the market is currently...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/is-there-now-an-opportunity-in-becton-dickinson-bdx-after-re","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/is-there-now-an-opportunity-in-becton-dickinson-bdx-after-re","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1854103824.USD","BDX","BK7067","LU0072461881.USD","LU0648000940.SGD","LU1150488135.SGD","LU0289961442.SGD","LU0878866978.SGD","BK4082","LU1894683348.USD","LU0068578508.USD","LU0511384066.AUD","LU1571399168.USD","BDX.AU","LU0130518102.USD","LU1150488218.USD","LU1059921491.USD","LU0477156797.USD","LU0130103400.USD","LU1489326972.SGD","BK4504","LU1201861165.SGD","LU1894683264.USD","BK4588","LU0985489474.SGD","BK4585","LU0289739343.SGD","LU0266013472.USD","LU1854104046.USD","LU0433182093.SGD","LU0985320562.USD","IE00BFXG1179.USD","LU0006061336.USD","DCF","LU0162691827.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613781993","title":"Becton Dickinson Launches Three-Tube Urine Collection System","url":"https://stock-news.laohu8.com/highlight/detail?id=2613781993","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613781993?lang=en_us&edition=fundamental","pubTime":"2026-02-23 20:17","pubTimestamp":1771849074,"startTime":"0","endTime":"0","summary":"Becton, Dickinson  said Monday it has launched the BD Vacutainer Urine Complete Cup Kit, a three-tube collection system.The company said the product is designed to preserve sample integrity, improve workflow efficiency, reduce exposure risks for healthcare workers, and minimize the need for repeat patient collections.The kit is available in the US with both Hemogard and conventional stoppered tubes and is compatible with a range of diagnostic equipment, the company said. It can support testing to detect and identify bacteria or fungi causing infection, as well as general wellness and signs of disease, BD said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1059921491.USD","LU0648000940.SGD","LU1854103824.USD","LU0068578508.USD","LU0130518102.USD","LU1150488135.SGD","LU0985489474.SGD","LU0878866978.SGD","LU0266013472.USD","LU1489326972.SGD","LU1571399168.USD","LU1894683348.USD","BK4504","LU0130103400.USD","BK7067","LU0006061336.USD","LU0985320562.USD","LU1854104046.USD","LU0289961442.SGD","LU0162691827.USD","BDX.AU","LU0289739343.SGD","IE00BFXG1179.USD","BK4082","LU0433182093.SGD","BDX","LU0511384066.AUD","LU1894683264.USD","LU1150488218.USD","BK4585","LU0477156797.USD","LU1201861165.SGD","BK4588","LU0072461881.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613207278","title":"Evaluating Becton Dickinson (BDX) After Earnings Strength Guidance Reaffirmation And Debt Tender Activity","url":"https://stock-news.laohu8.com/highlight/detail?id=2613207278","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613207278?lang=en_us&edition=fundamental","pubTime":"2026-02-23 15:19","pubTimestamp":1771831196,"startTime":"0","endTime":"0","summary":"Becton Dickinson (BDX) shares are back in focus after the company reported first quarter earnings and reaffirmed its full year 2026 guidance, as well as launching a US$1.6b tender offer for outstanding debt securities.\nSee our latest analysis for Becton Dickinson.\nAt a share price of US$185.39, Becton Dickinson has seen near term momentum pick up, with a 1 day share price return of 1.6% and 7 day share price return of 5.4%, following earnings, buyback activity and the US$1.6b debt tender. Its...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/evaluating-becton-dickinson-bdx-after-earnings-strength-guid","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/evaluating-becton-dickinson-bdx-after-earnings-strength-guid","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BDX.AU","BDX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":48,"code":"91000000","status":"200"}]}}